|
SIRO Clinpharm expands operations in Europe.
Opens office in Czech Republic strengthening its service offerings.
Mumbai, India and Prague, Czech Republic - Sep 08th 2009 - SIRO Clinpharm, a
global Contract Research Organization (CRO) with a base in India, US, Europe and Israel today announced the
opening its office in Prague, Czech Republic.
“Czech Republic has an excellent resource base of GCP trained, well qualified clinical research personnel,” said
Scott Spector, President, Strategic Operations, Europe. “Our new office in Czech Republic will further strengthen
our operational capabilities in Europe,” he added.
Dr. Ladislav Pecen, Country Manager will be in charge of operations in Czech Republic for SIRO. To begin with
SIRO will roll out Clinical Monitoring, Biostatistics and Statistical Programming services from the new office.
From its offices in Offenbach, Germany and Mumbai, India SIRO has been offering these and other services like
Clinical Data Management, Quality Assurance and Medical Writing, Medical Affairs & Pharmacovigilance for more
than a decade.
“We established our presence in Europe with the acquisition of Omega Mediation, a Germany based CRO in April
2008. During the last 18 months, as a part of our global strategy, we have expanded our capabilities by
opening offices in North East and South East Europe. Our Czech Republic office will consolidate our position
in Central Europe.” said Dr. Chetan Tamhankar, Chief Operating Officer of SIRO Clinpharm. “We will definitely
not stop here and have already started eyeing other countries in Western Europe for further expansion,” he
added.
SIRO has a rich experience servicing top global pharma and biotech firms since its inception in 1996 in India.
|
